{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:37:14Z","timestamp":1785317834925,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.clbc.2019.12.006","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T13:07:17Z","timestamp":1576760837000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8849-3350","authenticated-orcid":false,"given":"Elana","family":"Nack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Koffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara Lynne","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6467-5352","authenticated-orcid":false,"given":"Mary Anne","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don S.","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Wazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw T.","family":"Hepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.12.006_bib1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.12.006_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.12.006_bib3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2019.12.006_bib4","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2019.12.006_bib5","doi-asserted-by":"crossref","first-page":"317659","DOI":"10.4061\/2011\/317659","article-title":"Radiation-induced heart disease: a clinical update","volume":"2011","author":"Yusuf","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.clbc.2019.12.006_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1378\/chest.99.3.538","article-title":"Radiation-associated valvular disease","volume":"99","author":"Carlson","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.clbc.2019.12.006_bib7","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2019.12.006_bib8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","article-title":"Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy","volume":"12","author":"Cuzick","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.12.006_bib10","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.2008.17.9549","article-title":"Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG phase III trial N9831","volume":"27","author":"Halyard","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2019.12.006_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2019.12.006_bib13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.09.022","article-title":"Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy","volume":"85","author":"Erven","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2019.12.006_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1748-717X-6-151","article-title":"Myocardial perfusion imaging with 99mTc-tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case\u2013control study","volume":"6","author":"Sioka","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2014.11.016","article-title":"Subclinical cardiac dysfunction detected by strain imaging during breast irradiation with persistent changes 6 weeks after treatment","volume":"92","author":"Lo","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2019.12.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.clbc.2019.12.006_bib17","author":"Scheiner"},{"key":"10.1016\/j.clbc.2019.12.006_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12350-008-9027-z","article-title":"ASNC guidelines for ERNA, 2009","volume":"16","author":"Corbett","year":"2009","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.clbc.2019.12.006_bib19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.12.006_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamaoncol.2015.3709","article-title":"Cardiac outcomes of patients receiving adjuvant weekly paclitaxel and trastuzumab for node-negative, ERBB2-positive breast cancer","volume":"2","author":"Dang","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.2015.61.8413","article-title":"Long-term cardiac safety analysis of NCCTG N9831 (Alliance) adjuvant trastuzumab trial","volume":"34","author":"Advani","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib22","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1200\/JCO.2005.02.4091","volume":"23","author":"Tan-Chiu","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib23","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.2007.13.5467","article-title":"Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial","volume":"26","author":"Perez","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11739-015-1362-x","article-title":"Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer","volume":"11","author":"Mantarro","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clbc.2019.12.006_bib25","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2013.53.9288","article-title":"Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01)","volume":"32","author":"de Azambuja","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib26","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib27","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2011.40.0010","volume":"30","author":"Romond","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/annonc\/mdn029","article-title":"Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study","volume":"19","author":"Belkac\u00e9mi","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2008.09.003","article-title":"Acute cardiotoxicity with concurrent trastuzumab and radiotherapy including internal mammary chain nodes: a retrospective single-institution study","volume":"90","author":"Shaffer","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2010.08.013","article-title":"The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study","volume":"47","author":"Caussa","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2019.12.006_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10549-014-3166-5","article-title":"Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study","volume":"148","author":"Jacob","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.12.006_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiotherapy: a systematic review of heart doses published during 2003-2013","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clbc.2019.12.006_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pgmj.71.833.164","article-title":"Sarialio\u01e7lu F, \u00d6zbarlas N, B\u00fcy\u00fckpamuk\u00e7u M, Aky\u00fcz C, Kutluk T. Late cardiac effects after treatment for childhood Hodgkin\u2019s disease with chemotherapy and low-dose radiotherapy","volume":"71","author":"Ilhan","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clbc.2019.12.006_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.1993.tb03136.x","article-title":"Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin\u2019s disease","volume":"84","author":"Kreuser","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clbc.2019.12.006_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/hrt.75.6.591","article-title":"Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin\u2019s disease: an echocardiographic study","volume":"75","author":"Lund","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.clbc.2019.12.006_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-year survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.12.006_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2011.06.016","article-title":"Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden","volume":"100","author":"McGale","year":"2011","journal-title":"Radiother Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919307657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919307657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:36Z","timestamp":1761513576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919307657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1526820919307657"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.12.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}